Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 1
1977 1
1979 8
1980 3
1981 7
1982 5
1983 3
1984 12
1985 7
1986 4
1987 2
1988 10
1989 5
1990 3
1991 4
1992 6
1993 5
1994 2
1995 8
1996 3
1997 7
1998 8
1999 6
2000 5
2001 3
2002 7
2003 10
2004 5
2005 1
2006 9
2007 6
2008 8
2009 5
2010 3
2011 7
2012 6
2013 7
2014 8
2015 13
2016 6
2017 9
2018 16
2019 10
2020 11
2021 9
2022 2
Text availability
Article attribute
Article type
Publication date

Search Results

257 results
Results by year
Filters applied: . Clear all
Page 1
Showing results for bolli g[au]
Your search for Molli G[au] retrieved no results
More Similarities Than Differences Testing Insulin Glargine 300 Units/mL Versus Insulin Degludec 100 Units/mL in Insulin-Naive Type 2 Diabetes: The Randomized Head-to-Head BRIGHT Trial.
Rosenstock J, Cheng A, Ritzel R, Bosnyak Z, Devisme C, Cali AMG, Sieber J, Stella P, Wang X, Frías JP, Roussel R, Bolli GB. Rosenstock J, et al. Among authors: bolli gb. Diabetes Care. 2018 Oct;41(10):2147-2154. doi: 10.2337/dc18-0559. Epub 2018 Aug 13. Diabetes Care. 2018. PMID: 30104294 Clinical Trial.
Differential glycaemic control with basal insulin glargine 300 U/mL versus degludec 100 U/mL according to kidney function in type 2 diabetes: A subanalysis from the BRIGHT trial.
Haluzík M, Cheng A, Müller-Wieland D, Westerbacka J, Bosnyak Z, Lauand F, Melas-Melt L, Karalliedde J, Rosenstock J, Bolli GB. Haluzík M, et al. Among authors: bolli gb. Diabetes Obes Metab. 2020 Aug;22(8):1369-1377. doi: 10.1111/dom.14043. Epub 2020 Apr 28. Diabetes Obes Metab. 2020. PMID: 32243043 Free PMC article. Clinical Trial.
New insulin glargine 300 U/ml compared with glargine 100 U/ml in insulin-naïve people with type 2 diabetes on oral glucose-lowering drugs: a randomized controlled trial (EDITION 3).
Bolli GB, Riddle MC, Bergenstal RM, Ziemen M, Sestakauskas K, Goyeau H, Home PD; on behalf of the EDITION 3 study investigators. Bolli GB, et al. Diabetes Obes Metab. 2015 Apr;17(4):386-94. doi: 10.1111/dom.12438. Epub 2015 Feb 12. Diabetes Obes Metab. 2015. PMID: 25641260 Free PMC article. Clinical Trial.
New insulin glargine 300 units/mL versus glargine 100 units/mL in people with type 2 diabetes using basal and mealtime insulin: glucose control and hypoglycemia in a 6-month randomized controlled trial (EDITION 1).
Riddle MC, Bolli GB, Ziemen M, Muehlen-Bartmer I, Bizet F, Home PD; EDITION 1 Study Investigators. Riddle MC, et al. Among authors: bolli gb. Diabetes Care. 2014 Oct;37(10):2755-62. doi: 10.2337/dc14-0991. Epub 2014 Jul 30. Diabetes Care. 2014. PMID: 25078900 Clinical Trial.
Hypoglycaemia unawareness.
Bolli GB. Bolli GB. Diabetes Metab. 1997 Sep;23 Suppl 3:29-35. Diabetes Metab. 1997. PMID: 9342540 Review.
Insulins today and beyond.
Owens DR, Zinman B, Bolli GB. Owens DR, et al. Among authors: bolli gb. Lancet. 2001 Sep 1;358(9283):739-46. doi: 10.1016/S0140-6736(01)05842-1. Lancet. 2001. PMID: 11551598 Review.
Hypoglycemia, diabetes, and cardiovascular events.
Desouza CV, Bolli GB, Fonseca V. Desouza CV, et al. Among authors: bolli gb. Diabetes Care. 2010 Jun;33(6):1389-94. doi: 10.2337/dc09-2082. Diabetes Care. 2010. PMID: 20508232 Free PMC article. Review. No abstract available.
Glucose variability and complications.
Bolli GB. Bolli GB. Diabetes Care. 2006 Jul;29(7):1707-9. doi: 10.2337/dc06-0716. Diabetes Care. 2006. PMID: 16801607 No abstract available.
Pharmacokinetics and pharmacodynamics of basal insulins.
Porcellati F, Bolli GB, Fanelli CG. Porcellati F, et al. Among authors: bolli gb. Diabetes Technol Ther. 2011 Jun;13 Suppl 1:S15-24. doi: 10.1089/dia.2011.0038. Diabetes Technol Ther. 2011. PMID: 21668333 Review.
257 results